TELA Bio Inc (TELA)
2.63
+0.01
(+0.38%)
USD |
NASDAQ |
Sep 27, 16:00
2.62
-0.01
(-0.38%)
After-Hours: 20:00
TELA Bio SG&A Expense (TTM): 81.09M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 81.09M |
March 31, 2024 | 78.82M |
December 31, 2023 | 74.57M |
September 30, 2023 | 68.24M |
June 30, 2023 | 64.74M |
March 31, 2023 | 61.38M |
December 31, 2022 | 57.11M |
September 30, 2022 | 53.81M |
June 30, 2022 | 49.52M |
March 31, 2022 | 45.30M |
December 31, 2021 | 41.52M |
Date | Value |
---|---|
September 30, 2021 | 39.18M |
June 30, 2021 | 37.72M |
March 31, 2021 | 33.52M |
December 31, 2020 | 32.25M |
September 30, 2020 | 30.88M |
June 30, 2020 | 27.87M |
March 31, 2020 | 26.75M |
December 31, 2019 | 24.28M |
September 30, 2019 | 21.96M |
June 30, 2019 | 21.03M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
21.96M
Minimum
Sep 2019
81.09M
Maximum
Jun 2024
47.53M
Average
43.41M
Median
SG&A Expense (TTM) Benchmarks
Cutera Inc | 144.63M |
IRIDEX Corp | 24.53M |
Stereotaxis Inc | 26.39M |
Electromed Inc | 34.49M |
Myomo Inc | 20.12M |